BD (Becton, Dickinson and Company) and Babson Diagnostics announced on December 17, 2024, an expansion of their fingertip blood collection and testing technologies for use by U.S. health systems and other large provider networks. This innovative process integrates BD's MiniDraw™ Capillary Blood Collection System with Babson's BetterWay technologies.
The solution enables accurate test results from as few as six drops of capillary blood collected from a patient's finger, offering a less-invasive alternative to traditional venipuncture blood draws. Samples can be collected and prepared by any trained healthcare worker, including those without prior phlebotomy experience.
This technology aims to improve access to blood testing in underserved locations lacking phlebotomy capabilities and lower barriers such as fear of needles and logistical challenges. The commercial partnership builds on a collaboration that began in 2016, now extending to ambulatory care sites across the United States.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.